HER2 Gene Copy Number Status May Influence Clinical Efficacy to Anti-Egfr Monoclonal Antibodies in Metastatic Colorectal Cancer Patients

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

EGFR Gene Copy Number Assessment From Areas With Highest EGFR Expression Predicts Response to Anti-Egfr Therapy in Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2011English

EGFRgene Copy Number Predicts Response to Anti-Egfr Treatment inRASwild Type andRAS/BRAF/PIK3CAwild Type Metastatic Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2016English

HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Comment on ‘Clinical Significance of BRAF Non-V600e Mutations on the Therapeutic Effects of Anti-Egfr Monoclonal Antibody Treatment in Patients With Pretreated Metastatic Colorectal Cancer: The Biomarker Research for Anti-Egfr Monoclonal Antibodies by Comprehensive Cancer Genomics (BREAC) Study’

British Journal of Cancer
Cancer ResearchOncology
2018English

Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Development and Clinical Application of Anti-Her2 Monoclonal and Bispecific Antibodies for Cancer Treatment

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2017English

Clinical Significance of HER2 and EGFR Expression in Colorectal Cancer Patients With Ovarian Metastasis

BMC Clinical Pathology
Forensic MedicinePathologyHistology
2019English

Prognostic and Predictive Values of EGFR Overexpression and EGFR Copy Number Alteration in HER2-positive Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy